User menu

Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA)

Bibliographic reference Sartelli, M. ; Weber, D.G. ; Ruppé, E. ; Bassetti, M. ; Wright, B.J. ; et. al. Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). In: World Journal of Emergency Surgery, Vol. 11, no.Issue 1, p. Article number 33 (15 July 2016)
Permanent URL
  1. Dellit Timothy H., Owens Robert C., McGowan John E., Gerding Dale N., Weinstein Robert A., Burke John P., Huskins W. Charles, Paterson David L., Fishman Neil O., Carpenter Christopher F., Brennan P. J., Billeter Marianne, Hooton Thomas M., Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship, 10.1086/510393
  2. Rice Louis B., Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE, 10.1086/533452
  3. Boucher Helen W., Talbot George H., Bradley John S., Edwards John E., Gilbert David, Rice Louis B., Scheld Michael, Spellberg Brad, Bartlett John, Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America, 10.1086/595011
  4. Rao G Gopal, Risk Factors for the Spread of Antibiotic-Resistant Bacteria : , 10.2165/00003495-199855030-00001
  5. P.D. Deege Marjolein, L. Paterson David, Reducing the Development of Antibiotic Resistance in Critical Care Units, 10.2174/138920111798808301
  6. Septimus Edward J., Owens Robert C., Need and Potential of Antimicrobial Stewardship in Community Hospitals, 10.1093/cid/cir363
  7. Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC), 10.1016/0196-6553(95)90104-3
  8. Donskey Curtis J., Antibiotic Regimens and Intestinal Colonization with Antibiotic-Resistant Gram-Negative Bacilli, 10.1086/504481
  9. SALYERS A, GUPTA A, WANG Y, Human intestinal bacteria as reservoirs for antibiotic resistance genes, 10.1016/j.tim.2004.07.004
  10. Vollaard E J, Clasener H A, Colonization resistance., 10.1128/aac.38.3.409
  11. Bhalla Anita, Pultz Nicole J., Ray Amy J., Hoyen Claudia K., Eckstein Elizabeth C., Donskey Curtis J., Antianaerobic Antibiotic Therapy Promotes Overgrowth of Antibiotic-Resistant, Gram-Negative Bacilli and Vancomycin-Resistant Enterococci in the Stool of Colonized Patients, 10.1086/502267
  12. Donskey Curtis J., Chowdhry Tanvir K., Hecker Michelle T., Hoyen Claudia K., Hanrahan Jennifer A., Hujer Andrea M., Hutton-Thomas Rebecca A., Whalen Christopher C., Bonomo Robert A., Rice Louis B., Effect of Antibiotic Therapy on the Density of Vancomycin-Resistant Enterococci in the Stool of Colonized Patients, 10.1056/nejm200012283432604
  13. Taur Ying, Xavier Joao B., Lipuma Lauren, Ubeda Carles, Goldberg Jenna, Gobourne Asia, Lee Yeon Joo, Dubin Krista A., Socci Nicholas D., Viale Agnes, Perales Miguel-Angel, Jenq Robert R., van den Brink Marcel R. M., Pamer Eric G., Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation, 10.1093/cid/cis580
  14. Ruppe E., Lixandru B., Cojocaru R., Buke C., Paramythiotou E., Angebault C., Visseaux C., Djuikoue I., Erdem E., Burduniuc O., El Mniai A., Marcel C., Perrier M., Kesteman T., Clermont O., Denamur E., Armand-Lefevre L., Andremont A., Relative Fecal Abundance of Extended-Spectrum- -Lactamase-Producing Escherichia coli Strains and Their Occurrence in Urinary Tract Infections in Women, 10.1128/aac.00238-13
  15. Paphitou Niki I., Antimicrobial resistance: action to combat the rising microbial challenges, 10.1016/j.ijantimicag.2013.04.007
  16. Pulcini Céline, Gyssens Inge C., How to educate prescribers in antimicrobial stewardship practices, 10.4161/viru.23706
  17. Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology. 1981;81:5–9.
  18. Sartelli Massimo, Malangoni Mark A., Abu-Zidan Fikri M., Griffiths Ewen A., Di Bella Stefano, McFarland Lynne V., Eltringham Ian, Shelat Vishal G., Velmahos George C., Kelly Ciarán P., Khanna Sahil, Abdelsattar Zaid M., Alrahmani Layan, Ansaloni Luca, Augustin Goran, Bala Miklosh, Barbut Frédéric, Ben-Ishay Offir, Bhangu Aneel, Biffl Walter L., Brecher Stephen M., Camacho-Ortiz Adrián, Caínzos Miguel A., Canterbury Laura A., Catena Fausto, Chan Shirley, Cherry-Bukowiec Jill R., Clanton Jesse, Coccolini Federico, Cocuz Maria Elena, Coimbra Raul, Cook Charles H., Cui Yunfeng, Czepiel Jacek, Das Koray, Demetrashvili Zaza, Di Carlo Isidoro, Di Saverio Salomone, Dumitru Irina Magdalena, Eckert Catherine, Eckmann Christian, Eiland Edward H., Enani Mushira Abdulaziz, Faro Mario, Ferrada Paula, Forrester Joseph Derek, Fraga Gustavo P., Frossard Jean Louis, Galeiras Rita, Ghnnam Wagih, Gomes Carlos Augusto, Gorrepati Venkata, Ahmed Mohamed Hassan, Herzog Torsten, Humphrey Felicia, Kim Jae Il, Isik Arda, Ivatury Rao, Lee Yeong Yeh, Juang Paul, Furuya-Kanamori Luis, Karamarkovic Aleksandar, Kim Peter K, Kluger Yoram, Ko Wen Chien, LaBarbera Francis D., Lee Jae Gil, Leppaniemi Ari, Lohsiriwat Varut, Marwah Sanjay, Mazuski John E., Metan Gokhan, Moore Ernest E., Moore Frederick Alan, Nord Carl Erik, Ordoñez Carlos A., Júnior Gerson Alves Pereira, Petrosillo Nicola, Portela Francisco, Puri Basant K., Ray Arnab, Raza Mansoor, Rems Miran, Sakakushev Boris E., Sganga Gabriele, Spigaglia Patrizia, Stewart David B., Tattevin Pierre, Timsit Jean Francois, To Kathleen B., Tranà Cristian, Uhl Waldemar, Urbánek Libor, van Goor Harry, Vassallo Angela, Zahar Jean Ralph, Caproli Emanuele, Viale Pierluigi, WSES guidelines for management of Clostridium difficile infection in surgical patients, 10.1186/s13017-015-0033-6
  19. Farrell RJ, LaMont JT. Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis. Curr Top Microbiol Immunol. 2000;250:109–25.
  20. Hensgens Marjolein P. M., Goorhuis Abraham, Dekkers Olaf M., Kuijper Ed J., Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics, 10.1093/jac/dkr508
  21. Muto Carlene A., Pokrywka Marian, Shutt Kathleen, Mendelsohn Aaron B., Nouri Kathy, Posey Kathy, Roberts Terri, Croyle Karen, Krystoflak Sharon, Patel-Brown Sujata, Pasculle A. William, Paterson David L., Saul Melissa, Harrison Lee H., A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use, 10.1086/502539
  22. Loo Vivian G., Poirier Louise, Miller Mark A., Oughton Matthew, Libman Michael D., Michaud Sophie, Bourgault Anne-Marie, Nguyen Tuyen, Frenette Charles, Kelly Mirabelle, Vibien Anne, Brassard Paul, Fenn Susan, Dewar Ken, Hudson Thomas J., Horn Ruth, René Pierre, Monczak Yury, Dascal André, A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality, 10.1056/nejmoa051639
  23. Pepin J., Saheb N., Coulombe M.-A., Alary M.-E., Corriveau M.-P., Authier S., Leblanc M., Rivard G., Bettez M., Primeau V., Nguyen M., Jacob C.-E., Lanthier L., Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in Quebec, 10.1086/496986
  24. Dubberke E. R., Reske K. A., Yan Y., Olsen M. A., McDonald L. C., Fraser V. J., Clostridium difficile--Associated Disease in a Setting of Endemicity: Identification of Novel Risk Factors, 10.1086/523582
  25. Owens, Jr. Robert C., Donskey Curtis J., Gaynes Robert P., Loo Vivian G., Muto Carlene A., Antimicrobial‐Associated Risk Factors forClostridium difficileInfection, 10.1086/521859
  26. McCusker Margaret E., Harris Anthony D., Perencevich Eli, Roghmann Mary-Claire, Fluoroquinolone Use andClostridium difficile–associated Diarrhea, 10.3201/eid0906.020385
  27. Leffler Daniel A., Lamont J. Thomas, Clostridium difficile Infection, 10.1056/nejmra1403772
  28. Slimings Claudia, Riley Thomas V., Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis, 10.1093/jac/dkt477
  29. Kim Peter K., Huh Heesun C., Cohen Hillel W., Feinberg Elyssa J., Ahmad Salman, Coyle Christina, Teperman Sheldon, Boothe Hugh, Intracolonic Vancomycin for SevereClostridium difficileColitis, 10.1089/sur.2012.158
  30. Neal Matthew D., Alverdy John C., Hall Daniel E., Simmons Richard L., Zuckerbraun Brian S., Diverting Loop Ileostomy and Colonic Lavage : An Alternative to Total Abdominal Colectomy for the Treatment of Severe, Complicated Clostridium difficile Associated Disease, 10.1097/sla.0b013e31822ade48
  31. Bougnoux M.-E., Diogo D., Francois N., Sendid B., Veirmeire S., Colombel J. F., Bouchier C., Van Kruiningen H., d'Enfert C., Poulain D., Multilocus Sequence Typing Reveals Intrafamilial Transmission and Microevolutions of Candida albicans Isolates from the Human Digestive Tract, 10.1128/jcm.44.5.1810-1820.2006
  32. Kam Angela P., Xu Jianping, Diversity of commensal yeasts within and among healthy hosts, 10.1016/s0732-8893(02)00364-4
  33. Xu J, Boyd CM, Livingston E, Meyer W, Madden JF, Mitchell TG. Species and genotypic diversities and similarities of pathogenic yeasts colonizing women. J Clin Microbiol. 1999;37:3835–43.
  34. Miranda L.N., van der Heijden I.M., Costa S.F., Sousa A.P.I., Sienra R.A., Gobara S., Santos C.R., Lobo R.D., Pessoa V.P., Levin A.S., Candida colonisation as a source for candidaemia, 10.1016/j.jhin.2009.02.009
  35. Yan Lei, Yang Chunhui, Tang Jianguo, Disruption of the intestinal mucosal barrier in Candida albicans infections, 10.1016/j.micres.2013.02.008
  36. Schulte Danielle M., Sethi Ajay, Gangnon Ronald, Duster Megan, Maki Dennis G., Safdar Nasia, Risk factors for Candida colonization and Co-colonization with multi-drug resistant organisms at admission, 10.1186/s13756-015-0089-9
  37. Aly Mahmoud, Balkhy Hanan H, The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council countries, 10.1186/2047-2994-1-26
  38. Laxminarayan Ramanan, Duse Adriano, Wattal Chand, Zaidi Anita K M, Wertheim Heiman F L, Sumpradit Nithima, Vlieghe Erika, Hara Gabriel Levy, Gould Ian M, Goossens Herman, Greko Christina, So Anthony D, Bigdeli Maryam, Tomson Göran, Woodhouse Will, Ombaka Eva, Peralta Arturo Quizhpe, Qamar Farah Naz, Mir Fatima, Kariuki Sam, Bhutta Zulfiqar A, Coates Anthony, Bergstrom Richard, Wright Gerard D, Brown Eric D, Cars Otto, Antibiotic resistance—the need for global solutions, 10.1016/s1473-3099(13)70318-9
  39. Ashiru-Oredope D., Cookson B., Fry C., Cookson B., Ashiru-Oredope D., Avery T., Baudouin S., Brown J., Cooke J., Cooper T., Crighton A., Davey P., Duerden B., Doherty L., Drabu Y., Fitzpatrick M., Fry C., Gallagher R., Howard P., Howe R., Kerr K., Johnson T., Khoda H., Leaper D., McNulty C., Nathwani D., Sharland M., Stockley J., Thomson A., Wellsteed S., White P., , Developing the first national antimicrobial prescribing and stewardship competences, 10.1093/jac/dku350
  40. Allegranzi Benedetta, Pittet Didier, Preventing infections acquired during health-care delivery, 10.1016/s0140-6736(08)61715-8
  41. ECDC. Annual epidemiological report. Antimicrobial resistance and healthcare-associated infections. . Accessed 03 Apr 2016.
  42. World Health Organization (WHO). Global action plan on antimicrobial resistance. . Accessed 03 Apr 2016.
  43. Huttner Angela, Harbarth Stephan, Carlet Jean, Cosgrove Sara, Goossens Herman, Holmes Alison, Jarlier Vincent, Voss Andreas, Pittet Didier, , Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum, 10.1186/2047-2994-2-31
  44. Liu Yi-Yun, Wang Yang, Walsh Timothy R, Yi Ling-Xian, Zhang Rong, Spencer James, Doi Yohei, Tian Guobao, Dong Baolei, Huang Xianhui, Yu Lin-Feng, Gu Danxia, Ren Hongwei, Chen Xiaojie, Lv Luchao, He Dandan, Zhou Hongwei, Liang Zisen, Liu Jian-Hua, Shen Jianzhong, Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study, 10.1016/s1473-3099(15)00424-7
  45. Pitout Johann DD, Laupland Kevin B, Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern, 10.1016/s1473-3099(08)70041-0
  47. Courpon-Claudinon A., Lefort A., Panhard X., Clermont O., Dornic Q., Fantin B., Mentré F., Wolff M., Denamur E., Branger C., Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features, 10.1111/j.1469-0691.2010.03298.x
  48. Thaden Joshua T., Fowler Vance G., Sexton Daniel J., Anderson Deverick J., Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States, 10.1017/ice.2015.239
  49. Makoka Mwai H, Miller William C, Hoffman Irving F, Cholera Rushina, Gilligan Peter H, Kamwendo Debbie, Malunga Gabriel, Joaki George, Martinson Francis, Hosseinipour Mina C, Bacterial infections in Lilongwe, Malawi: aetiology and antibiotic resistance, 10.1186/1471-2334-12-67
  50. McManus MC. Mechanisms of bacterial resistance to antimicrobial agents. Am J Health Syst Pharm. 1997;54:1420–33.
  51. Martinez J. L., Baquero F., Mutation Frequencies and Antibiotic Resistance, 10.1128/aac.44.7.1771-1777.2000
  52. Palmer Kelli L, Kos Veronica N, Gilmore Michael S, Horizontal gene transfer and the genomics of enterococcal antibiotic resistance, 10.1016/j.mib.2010.08.004
  53. Billard-Pomares T., Fouteau S., Jacquet M. E., Roche D., Barbe V., Castellanos M., Bouet J. Y., Cruveiller S., Medigue C., Blanco J., Clermont O., Denamur E., Branger C., Characterization of a P1-Like Bacteriophage Carrying an SHV-2 Extended-Spectrum  -Lactamase from an Escherichia coli Strain, 10.1128/aac.03183-14
  54. Brown-Jaque Maryury, Calero-Cáceres William, Muniesa Maite, Transfer of antibiotic-resistance genes via phage-related mobile elements, 10.1016/j.plasmid.2015.01.001
  55. Trueba G. Chapter Ten: The forces behind the dissemination of bacterial virulence and antibiotic resistance. In: Why does Evolution Matter? The Importance of Understanding Evolution. UK: Cambridge Scholars Publishing; 2014.
  56. Iida S., Meyer J., Arber W., Genesis and Natural History of IS-mediated Transposons, 10.1101/sqb.1981.045.01.006
  57. Poirel L., Marque S., Heritier C., Segonds C., Chabanon G., Nordmann P., OXA-58, a Novel Class D  -Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii, 10.1128/aac.49.1.202-208.2005
  58. Humeniuk C., Arlet G., Gautier V., Grimont P., Labia R., Philippon A.,  -Lactamases of Kluyvera ascorbata, Probable Progenitors of Some Plasmid-Encoded CTX-M Types, 10.1128/aac.46.9.3045-3049.2002
  59. Ray M. D., Boundy S., Archer G. L., Transfer of the methicillin resistance genomic island among staphylococci by conjugation : Transfer of the methicillin resistance, 10.1111/mmi.13340
  60. Chen L., Mathema B., Pitout J. D. D., DeLeo F. R., Kreiswirth B. N., Epidemic Klebsiella pneumoniae ST258 Is a Hybrid Strain, 10.1128/mbio.01355-14
  61. Smyth Davida S., McDougal Linda K., Gran Frode W., Manoharan Anand, Enright Mark C., Song Jae-Hoon, de Lencastre Herminia, Robinson D. Ashley, Population Structure of a Hybrid Clonal Group of Methicillin-Resistant Staphylococcus aureus, ST239-MRSA-III, 10.1371/journal.pone.0008582
  62. Bush Karen, Fisher Jed F., Epidemiological Expansion, Structural Studies, and Clinical Challenges of New β-Lactamases from Gram-Negative Bacteria, 10.1146/annurev-micro-090110-102911
  63. Ambler R. P., The Structure of $\beta$-Lactamases, 10.1098/rstb.1980.0049
  64. Bush K., Jacoby G. A., Medeiros A. A., A functional classification scheme for beta-lactamases and its correlation with molecular structure, 10.1128/aac.39.6.1211
  65. Bush K., Jacoby G. A., Updated Functional Classification of  -Lactamases, 10.1128/aac.01009-09
  66. Ruppé Étienne, Woerther Paul-Louis, Barbier François, Mechanisms of antimicrobial resistance in Gram-negative bacilli, 10.1186/s13613-015-0061-0
  67. Jacoby G. A., AmpC  -Lactamases, 10.1128/cmr.00036-08
  68. Kang Cheol-In, Pai Hyunjoo, Kim Sung-Han, Kim Hong-Bin, Kim Eui-Chong, Oh Myoung-don, Choe Kang-Won, Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type β-lactamase, 10.1093/jac/dkh462
  69. Tamma Pranita D., Girdwood Sonya C. T., Gopaul Ravindra, Tekle Tsigereda, Roberts Ava A., Harris Anthony D., Cosgrove Sara E., Carroll Karen C., The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae, 10.1093/cid/cit395
  70. Schultsz Constance, Geerlings Suzanne, Plasmid-Mediated Resistance in Enterobacteriaceae : Changing Landscape and Implications for Therapy, 10.2165/11597960-000000000-00000
  71. Dalhoff Axel, Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use, 10.1155/2012/976273
  72. Brolund A. Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective. Infect Ecol Epidemiol. 2014;1:4.
  73. Perez F., Bonomo R. A., Can We Really Use ss-Lactam/ss-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ss-Lactamase-Producing Bacteria?, 10.1093/cid/cir793
  74. Roberts J. A., Paul S. K., Akova M., Bassetti M., De Waele J. J., Dimopoulos G., Kaukonen K.-M., Koulenti D., Martin C., Montravers P., Rello J., Rhodes A., Starr T., Wallis S. C., Lipman J., Roberts J. A., Lipman J., Starr T., Wallis S. C., Paul S. K., Margarit Ribas A., De Waele J. J., De Crop L., Spapen H., Wauters J., Dugernier T., Jorens P., Dapper I., De Backer D., Taccone F. S., Rello J., Ruano L., Afonso E., Alvarez-Lerma F., Gracia-Arnillas M. P., Fernandez F., Feijoo N., Bardolet N., Rovira A., Garro P., Colon D., Castillo C., Fernado J., Lopez M. J., Fernandez J. L., Arribas A. M., Teja J. L., Ots E., Carlos Montejo J., Catalan M., Prieto I., Gonzalo G., Galvan B., Blasco M. A., Meyer E., Del Nogal F., Vidaur L., Sebastian R., Garde P. M., Martin Velasco M. d. M., Zaragoza Crespo R., Esperatti M., Torres A., Montravers P., Baldesi O., Dupont H., Mahjoub Y., Lasocki S., Constantin J. M., Payen J. F., Martin C., Albanese J., Malledant Y., Pottecher J., Lefrant J.-Y., Jaber S., Joannes-Boyau O., Orban C., Ostermann M., McKenzie C., Berry W., Smith J., Lei K., Rubulotta F., Gordon A., Brett S., Stotz M., Templeton M., Rhodes A., Ebm C., Moran C., Kaukonen K.-M., Pettila V., Dimopoulos G., Koulenti D., Xristodoulou A., Theodorou V., Kouliatsis G., Sertaridou E., Anthopoulos G., Choutas G., Rantis T., Karatzas S., Balla M., Papanikolaou M., Myrianthefs P., Gavala A., Fildisis G., Koutsoukou A., Kyriakopoulou M., Petrochilou K., Kompoti M., Michalia M., Clouva-Molyvdas F.-M., Gkiokas G., Nikolakopoulos F., Psychogiou V., Malliotakis P., Akoumianaki E., Lilitsis E., Koulouras V., Nakos G., Kalogirou M., Komnos A., Zafeiridis T., Chaintoutis C., Arvaniti K., Matamis D., Chaintoutis C., Kydona C., Gritsi-Gerogianni N., Giasnetsova T., Giannakou M., Soultati I., Chytas I., Antoniadou E., Antipa E., Lathyris D., Koukoubani T., Paraforou T., Spiropoulou K., Bekos V., Spring A., Kalatzi T., Nikolaou H., Laskou M., Strouvalis I., Aloizos S., Kapogiannis S., Soldatou O., Bassetti M., Adembri C., Villa G., Giarratano A., Maurizio Raineri S., Cortegiani A., Montalto F., Strano M. T., Ranieri V. M., Sandroni C., De Pascale G., Molin A., Pelosi P., Montagnani L., Urbino R., Mastromauro I., De Rosa F. G., Ranieri V. M., Cardoso T., Afonso S., Goncalves-Pereira J., Baptista J. P., Akova M., Ozveren A., , DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?, 10.1093/cid/ciu027
  75. Paterson D. L., Bonomo R. A., Extended-Spectrum  -Lactamases: a Clinical Update, 10.1128/cmr.18.4.657-686.2005
  76. Woerther P.-L., Burdet C., Chachaty E., Andremont A., Trends in Human Fecal Carriage of Extended-Spectrum  -Lactamases in the Community: Toward the Globalization of CTX-M, 10.1128/cmr.00023-13
  77. Weldhagen G. F., Poirel L., Nordmann P., Ambler Class A Extended-Spectrum  -Lactamases in Pseudomonas aeruginosa: Novel Developments and Clinical Impact, 10.1128/aac.47.8.2385-2392.2003
  78. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995;8:557–84.
  79. Hammoudi D., Moubareck C. Ayoub, Aires J., Adaime A., Barakat A., Fayad N., Hakime N., Houmani M., Itani T., Najjar Z., Suleiman M., Sarraf R., Sarkis D. Karam, Countrywide spread of OXA-48 carbapenemase in Lebanon: surveillance and genetic characterization of carbapenem-non-susceptible Enterobacteriaceae in 10 hospitals over a one-year period, 10.1016/j.ijid.2014.07.017
  80. Poirel L., Heritier C., Tolun V., Nordmann P., Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae, 10.1128/aac.48.1.15-22.2004
  81. Lee J., Patel G., Huprikar S., Calfee D. P., Jenkins S. G., Decreased Susceptibility to Polymyxin B during Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection, 10.1128/jcm.02466-08
  82. Yigit H., Queenan A. M., Anderson G. J., Domenech-Sanchez A., Biddle J. W., Steward C. D., Alberti S., Bush K., Tenover F. C., Novel Carbapenem-Hydrolyzing  -Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae, 10.1128/aac.45.4.1151-1161.2001
  83. Ducomble T., Faucheux S., Helbig U., Kaisers U.X., König B., Knaust A., Lübbert C., Möller I., Rodloff A.C., Schweickert B., Eckmanns T., Large hospital outbreak of KPC-2-producing Klebsiella pneumoniae: investigating mortality and the impact of screening for KPC-2 with polymerase chain reaction, 10.1016/j.jhin.2014.11.012
  84. Lübbert Christoph, Lippmann Norman, Busch Thilo, Kaisers Udo X., Ducomble Tanja, Eckmanns Tim, Rodloff Arne C., Long-term carriage of Klebsiella pneumoniae carbapenemase–2-producing K pneumoniae after a large single-center outbreak in Germany, 10.1016/j.ajic.2013.12.001
  85. Lübbert Christoph, Rodloff Arne C., Laudi Sven, Simon Philipp, Busch Thilo, Mössner Joachim, Bartels Michael, Kaisers Udo X., Lessons learned from excess mortality associated withKlebsiella pneumoniaecarbapenemase 2-producingk. pneumoniaein liver transplant recipients : LETTER FROM THE FRONTLINE, 10.1002/lt.23858
  86. Tzouvelekis L.S., Markogiannakis A., Piperaki E., Souli M., Daikos G.L., Treating infections caused by carbapenemase-producing Enterobacteriaceae, 10.1111/1469-0691.12697
  87. Munoz-Price L Silvia, Poirel Laurent, Bonomo Robert A, Schwaber Mitchell J, Daikos George L, Cormican Martin, Cornaglia Giuseppe, Garau Javier, Gniadkowski Marek, Hayden Mary K, Kumarasamy Karthikeyan, Livermore David M, Maya Juan J, Nordmann Patrice, Patel Jean B, Paterson David L, Pitout Johann, Villegas Maria Virginia, Wang Hui, Woodford Neil, Quinn John P, Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases, 10.1016/s1473-3099(13)70190-7
  88. Palzkill Timothy, Metallo-β-lactamase structure and function : Metallo-β-lactamase structure and function, 10.1111/j.1749-6632.2012.06796.x
  89. Cornaglia Giuseppe, Giamarellou Helen, Rossolini Gian Maria, Metallo-β-lactamases: a last frontier for β-lactams?, 10.1016/s1473-3099(11)70056-1
  90. Yong D., Toleman M. A., Giske C. G., Cho H. S., Sundman K., Lee K., Walsh T. R., Characterization of a New Metallo- -Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India, 10.1128/aac.00774-09
  91. Brink A. J., Coetzee J., Clay C. G., Sithole S., Richards G. A., Poirel L., Nordmann P., Emergence of New Delhi Metallo-Beta-Lactamase (NDM-1) and Klebsiella pneumoniae Carbapenemase (KPC-2) in South Africa, 10.1128/jcm.05956-11
  92. Fàbrega Anna, Madurga Sergi, Giralt Ernest, Vila Jordi, Mechanism of action of and resistance to quinolones, 10.1111/j.1751-7915.2008.00063.x
  93. Jacoby George A., Mechanisms of Resistance to Quinolones, 10.1086/428052
  94. Ramirez Maria S., Tolmasky Marcelo E., Aminoglycoside modifying enzymes, 10.1016/j.drup.2010.08.003
  95. Kumari H., Balasubramanian D., Zincke D., Mathee K., Role of Pseudomonas aeruginosa AmpR on  -lactam and non- -lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics, 10.1099/jmm.0.070185-0
  96. Lister PD, Gardner VM, Sanders CC. Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin. Antimicrob Agents Chemother. 1999;43:882–9.
  97. Poole K., Efflux-mediated multiresistance in Gram-negative bacteria, 10.1111/j.1469-0691.2004.00763.x
  98. Venter Henrietta, Mowla Rumana, Ohene-Agyei Thelma, Ma Shutao, RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition, 10.3389/fmicb.2015.00377
  99. Li Hui, Luo Yi-Feng, Williams Bryan J., Blackwell Timothy S., Xie Can-Mao, Structure and function of OprD protein in Pseudomonas aeruginosa: From antibiotic resistance to novel therapies, 10.1016/j.ijmm.2011.10.001
  100. Manchanda Vikas, Sinha Sanchaita, Singh NP, Multidrug resistant Acinetobacter, 10.4103/0974-777x.68538
  101. Potron Anaïs, Poirel Laurent, Nordmann Patrice, Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiology, 10.1016/j.ijantimicag.2015.03.001
  102. Linden Peter, Optimizing Therapy for Vancomycin-Resistant Enterococci (VRE), 10.1055/s-2007-996410
  103. Chou YY, Lin TY, Lin JC, Wang NC, Peng MY, Chang FY. Vancomycin-resistant enterococcal bacteremia: Comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. J Microbiol Immunol Infect. 2008;41:124–9.
  104. Hollenbeck Brian L., Rice Louis B., Intrinsic and acquired resistance mechanisms in enterococcus, 10.4161/viru.21282
  105. Hodges T L, Zighelboim-Daum S, Eliopoulos G M, Wennersten C, Moellering R C, Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens., 10.1128/aac.36.1.121
  106. Marothi YA, Agnihotri H, Dubey D. Enterococcal resistance-an overview. Indian J Med Microbiol. 2005;23:214–9.
  107. Mahbub Alam Mohammed, Kobayashi Nobumichi, Ishino Masaho, Sumi Ayako, Kobayashi Ken-Ichiro, Uehara Nobuyuki, Watanabe Naoki, Detection of a Novelaph(2")Allele (aph[2"]-Ie) Conferring High-Level Gentamicin Resistance and a Spectinomycin Resistance Geneant(9)-Ia(aad9) in Clinical Isolates of Enterococci, 10.1089/mdr.2005.11.239
  108. Depardieu F., Podglajen I., Leclercq R., Collatz E., Courvalin P., Modes and Modulations of Antibiotic Resistance Gene Expression, 10.1128/cmr.00015-06
  109. Noskin Gary A., Vancomycin-resistant enterococci: Clinical, microbiologic, and epidemiologic features, 10.1016/s0022-2143(97)90054-8
  110. Fang Hong, Edlund Charlotta, Hedberg Maria, Nord Carl Erik, New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group, 10.1016/s0924-8579(02)00019-5
  111. Rasmussen B. A., Bush K., Tally F. B., Antimicrobial Resistance in Anaerobes, 10.1093/clinids/24.supplement_1.s110
  112. Gutacker Michaela, Valsangiacomo Claudio, Piffaretti Jean-Claude, Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes, 10.1099/00221287-146-5-1241
  113. Ang Lei, Brenwald Nigel P., Walker Rebecca M., Andrews Jenny, Fraise Adam, Carbapenem resistance in Bacteroides fragilis, 10.1093/jac/dkm062
  114. Ingham H.R., Eaton Sheila, Venables C.W., Adams P.C., BACTEROIDES FRAGILIS RESISTANT TO METRONIDAZOLE AFTER LONG-TERM THERAPY, 10.1016/s0140-6736(78)90655-4
  115. Diniz C. G., Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant, 10.1093/jac/dkh256
  116. Pumbwe Lilian, Chang Abraham, Smith Rachel L., Wexler Hannah M., BmeRABC5 Is a Multidrug Efflux System That Can Confer Metronidazole Resistance inBacteroides fragilis, 10.1089/mdr.2007.719
  117. Nagy E., Urbán E., Nord Carl Erik, Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience, 10.1111/j.1469-0691.2010.03256.x
  118. Sartelli Massimo, Catena Fausto, di Saverio Salomone, Ansaloni Luca, Coccolini Federico, Tranà Cristian, Kirkby-Bott James, The Challenge of Antimicrobial Resistance in Managing Intra-Abdominal Infections, 10.1089/sur.2013.262
  119. Morrissey Ian, Hackel Meredith, Badal Robert, Bouchillon Sam, Hawser Stephen, Biedenbach Douglas, A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011, 10.3390/ph6111335
  120. Hawser S. P., Bouchillon S. K., Hoban D. J., Badal R. E., Canton R., Baquero F., Incidence and Antimicrobial Susceptibility of Escherichia coli and Klebsiella pneumoniae with Extended-Spectrum  -Lactamases in Community- and Hospital-Associated Intra-Abdominal Infections in Europe: Results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART), 10.1128/aac.00265-10
  121. Sartelli Massimo, Catena Fausto, Ansaloni Luca, Coccolini Federico, Corbella Davide, Moore Ernest E, Malangoni Mark, Velmahos George, Coimbra Raul, Koike Kaoru, Leppaniemi Ari, Biffl Walter, Balogh Zsolt, Bendinelli Cino, Gupta Sanjay, Kluger Yoram, Agresta Ferdinando, Saverio Salomone, Tugnoli Gregorio, Jovine Elio, Ordonez Carlos A, Whelan James F, Fraga Gustavo P, Gomes Carlos, Pereira Gerson, Yuan Kuo-Ching, Bala Miklosh, Peev Miroslav P, Ben-Ishay Offir, Cui Yunfeng, Marwah Sanjay, Zachariah Sanoop, Wani Imtiaz, Rangarajan Muthukumaran, Sakakushev Boris, Kong Victor, Ahmed Adamu, Abbas Ashraf, Gonsaga Ricardo Alessandro, Guercioni Gianluca, Vettoretto Nereo, Poiasina Elia, Díaz-Nieto Rafael, Massalou Damien, Skrovina Matej, Gerych Ihor, Augustin Goran, Kenig Jakub, Khokha Vladimir, Tranà Cristian, Kok Kenneth Yuh, Mefire Alain, Lee Jae, Hong Suk-Kyung, Lohse Helmut Alfredo, Ghnnam Wagih, Verni Alfredo, Lohsiriwat Varut, Siribumrungwong Boonying, El Zalabany Tamer, Tavares Alberto, Baiocchi Gianluca, Das Koray, Jarry Julien, Zida Maurice, Sato Norio, Murata Kiyoshi, Shoko Tomohisa, Irahara Takayuki, Hamedelneel Ahmed O, Naidoo Noel, Adesunkanmi Abdul Rashid, Kobe Yoshiro, Ishii Wataru, Oka Kazuyuki, Izawa Yoshimitsu, Hamid Hytham, Khan Iqbal, Attri AK, Sharma Rajeev, Sanjuan Juan, Badiel Marisol, Barnabé Rita, Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study, 10.1186/1749-7922-9-37
  122. Hawser S. P., Bouchillon S. K., Lascols C., Hackel M., Hoban D. J., Badal R. E., Woodford N., Livermore D. M., Susceptibility of Klebsiella pneumoniae Isolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant Isolates, 10.1128/aac.00070-11
  123. Babinchak Tim, Badal Robert, Hoban Daryl, Hackel Meredith, Hawser Stephen, Lob Sibylle, Bouchillon Samuel, Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005–2010, 10.1016/j.diagmicrobio.2013.02.031
  124. Sitges-Serra A., Lopez M. J., Girvent M., Almirall S., Sancho J. J., Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis, 10.1046/j.0007-1323.2001.02023.x
  125. Burnett Robert J., Haverstock Daniel C., Dellinger E. Patchen, Reinhart Harald H., Bohnen John M., Rotstein Ori D., Vogel Stephen B., Solomkin Joseph S., Definition of the role of enterococcus in intraabdominal infection: Analysis of a prospective randomized trial, 10.1016/s0039-6060(05)80040-6
  126. Dupont H., Friggeri A., Touzeau J., Airapetian N., Tinturier F., Lobjoie E., Lorne E., Hijazi M., Regimbeau J.-M., Mahjoub Y., Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit, 10.1093/jac/dkr308
  127. Kaffarnik MF, Urban M, Hopt UT, Utzolino S. Impact of enterococcus on immunocompetent and immunosuppressed patients with perforation of the small or large bowel. Technol Health Care. 2012;20:37–48.
  128. Ruler O., , Kiewiet J. J. S., Ketel R. J., Boermeester M. A., Initial microbial spectrum in severe secondary peritonitis and relevance for treatment, 10.1007/s10096-011-1357-0
  129. Montravers P., Lepape A., Dubreuil L., Gauzit R., Pean Y., Benchimol D., Dupont H., Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study, 10.1093/jac/dkp005
  130. Verma H, Pandey S, Sheoran KD, Marwah S. Surgical audit of patients with ileal perforations requiring ileostomy in a Tertiary Care Hospital in India. Surg Res Pract. 2015;2015:351548.
  131. Mirza S. H., Beechmg N. J., Hart C. A., Multi-drug resistant typhoid: a global problem, 10.1099/00222615-44-5-317
  132. Hammad OM, Abdel Wahab MF, Zaky S, Abdel Baki AM, Afify A, El Tantawi MA. Multidrug resistant typhoid fever in Egypt. J Med Lab Sci. 2007;16:57–63.
  133. Singhal L, Gautam V, Gupta PK, Kale P, Ray P, Trends in antimicrobial susceptibility ofSalmonellaTyphi from North India (2001-2012), 10.4103/0255-0857.129799
  134. Brook I., Wexler H. M., Goldstein E. J. C., Antianaerobic Antimicrobials: Spectrum and Susceptibility Testing, 10.1128/cmr.00086-12
  135. Snydman David R., Jacobus Nilda V., McDermott Laura A., Golan Yoav, Hecht David W., Goldstein Ellie J. C., Harrell Lizzie, Jenkins Stephen, Newton Duane, Pierson Carl, Rihs John D., Yu Victor L., Venezia Richard, Finegold Sydney M., Rosenblatt Jon E., Gorbach Sherwood L., Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data (2005–2007), 10.1086/647940
  136. Ramsay Craig, Brown Erwin, Hartman Giles, Davey Peter, Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing, 10.1093/jac/dkg460
  137. Dortch Marcus J., Fleming Sloan B., Kauffmann Rondi M., Dossett Lesly A., Talbot Thomas R., May Addison K., Infection Reduction Strategies Including Antibiotic Stewardship Protocols in Surgical and Trauma Intensive Care Units Are Associated with Reduced Resistant Gram-Negative Healthcare-Associated Infections, 10.1089/sur.2009.059
  138. White, Jr. A. Clinton, Atmar Robert L., Wilson Joan, Cate Thomas R., Stager Charles E., Greenberg Stephen B., Effects of Requiring prior Authorization for Selected Antimicrobials: Expenditures, Susceptibilities, and Clinical Outcomes, 10.1086/514545
  139. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4, CD003543.
  140. Marshall John C., Principles of Source Control in the Early Management of Sepsis, 10.1007/s11908-010-0126-z
  141. Wacha H., Hau T., Dittmer R., Ohmann C., Risk factors associated with intraabdominal infections: a prospective multicenter study, 10.1007/s004230050169
  142. Sartelli Massimo, Abu-Zidan Fikri M., Catena Fausto, Griffiths Ewen A., Di Saverio Salomone, Coimbra Raul, Ordoñez Carlos A., Leppaniemi Ari, Fraga Gustavo P., Coccolini Federico, Agresta Ferdinando, Abbas Asrhaf, Abdel Kader Saleh, Agboola John, Amhed Adamu, Ajibade Adesina, Akkucuk Seckin, Alharthi Bandar, Anyfantakis Dimitrios, Augustin Goran, Baiocchi Gianluca, Bala Miklosh, Baraket Oussama, Bayrak Savas, Bellanova Giovanni, Beltràn Marcelo A., Bini Roberto, Boal Matthew, Borodach Andrey V., Bouliaris Konstantinos, Branger Frederic, Brunelli Daniele, Catani Marco, Che Jusoh Asri, Chichom-Mefire Alain, Cocorullo Gianfranco, Colak Elif, Costa David, Costa Silvia, Cui Yunfeng, Curca Geanina Loredana, Curry Terry, Das Koray, Delibegovic Samir, Demetrashvili Zaza, Di Carlo Isidoro, Drozdova Nadezda, El Zalabany Tamer, Enani Mushira Abdulaziz, Faro Mario, Gachabayov Mahir, Giménez Maurel Teresa, Gkiokas Georgios, Gomes Carlos Augusto, Gonsaga Ricardo Alessandro Teixeira, Guercioni Gianluca, Guner Ali, Gupta Sanjay, Gutierrez Sandra, Hutan Martin, Ioannidis Orestis, Isik Arda, Izawa Yoshimitsu, Jain Sumita A., Jokubauskas Mantas, Karamarkovic Aleksandar, Kauhanen Saila, Kaushik Robin, Kenig Jakub, Khokha Vladimir, Kim Jae Il, Kong Victor, Koshy Renol, Krasniqi Avidyl, Kshirsagar Ashok, Kuliesius Zygimantas, Lasithiotakis Konstantinos, Leão Pedro, Lee Jae Gil, Leon Miguel, Lizarazu Pérez Aintzane, Lohsiriwat Varut, López-Tomassetti Fernandez Eudaldo, Lostoridis Eftychios, Mn Raghuveer, Major Piotr, Marinis Athanasios, Marrelli Daniele, Martinez-Perez Aleix, Marwah Sanjay, McFarlane Michael, Melo Renato Bessa, Mesina Cristian, Michalopoulos Nick, Moldovanu Radu, Mouaqit Ouadii, Munyika Akutu, Negoi Ionut, Nikolopoulos Ioannis, Nita Gabriela Elisa, Olaoye Iyiade, Omari Abdelkarim, Ossa Paola Rodríguez, Ozkan Zeynep, Padmakumar Ramakrishnapillai, Pata Francesco, Pereira Junior Gerson Alves, Pereira Jorge, Pintar Tadeja, Pouggouras Konstantinos, Prabhu Vinod, Rausei Stefano, Rems Miran, Rios-Cruz Daniel, Sakakushev Boris, Sánchez de Molina Maria Luisa, Seretis Charampolos, Shelat Vishal, Simões Romeo Lages, Sinibaldi Giovanni, Skrovina Matej, Smirnov Dmitry, Spyropoulos Charalampos, Tepp Jaan, Tezcaner Tugan, Tolonen Matti, Torba Myftar, Ulrych Jan, Uzunoglu Mustafa Yener, van Dellen David, van Ramshorst Gabrielle H., Vasquez Giorgio, Venara Aurélien, Vereczkei Andras, Vettoretto Nereo, Vlad Nutu, Yadav Sanjay Kumar, Yilmaz Tonguç Utku, Yuan Kuo-Ching, Zachariah Sanoop Koshy, Zida Maurice, Zilinskas Justas, Ansaloni Luca, Global validation of the WSES Sepsis Severity Score for patients with complicated intra-abdominal infections: a prospective multicentre study (WISS Study), 10.1186/s13017-015-0055-0
  143. vanSonnenberg E, Ferrucci J T, Mueller P R, Wittenberg J, Simeone J F, Percutaneous drainage of abscesses and fluid collections: technique, results, and applications., 10.1148/radiology.142.1.7053517
  144. Bouali K, Magotteaux P, Jadot A, Saive C, Lombard R, Weerts J, et al. Percutaneous catheter drainage of abdominal abscess after abdominal surgery: Results in 121 cases. J Belg Radiol. 1993;76:11–4.
  145. vanSonnenberg E, Wing VW, Casola G, Coons HG, Nakamoto SK, Mueller PR, Ferrucci JT, Halasz NA, Simeone JF, Temporizing effect of percutaneous drainage of complicated abscesses in critically ill patients, 10.2214/ajr.142.4.821
  146. Jaffe Tracy A., Nelson Rendon C., DeLong David M., Paulson Erik K., Practice Patterns in Percutaneous Image-guided Intraabdominal Abscess Drainage: Survey of Academic and Private Practice Centers, 10.1148/radiol.2333032063
  147. Kirkpatrick Andrew W., , Roberts Derek J., De Waele Jan, Jaeschke Roman, Malbrain Manu L. N. G., De Keulenaer Bart, Duchesne Juan, Bjorck Martin, Leppaniemi Ari, Ejike Janeth C., Sugrue Michael, Cheatham Michael, Ivatury Rao, Ball Chad G., Reintam Blaser Annika, Regli Adrian, Balogh Zsolt J., D’Amours Scott, Debergh Dieter, Kaplan Mark, Kimball Edward, Olvera Claudia, Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome, 10.1007/s00134-013-2906-z
  148. Kirkpatrick Andrew W., Roberts Derek J., Faris Peter D., Ball Chad G., Kubes Paul, Tiruta Corina, Xiao Zhengwen, Holodinsky Jessalyn K., McBeth Paul B., Doig Christopher J., Jenne Craig N., Active Negative Pressure Peritoneal Therapy After Abbreviated Laparotomy : The Intraperitoneal Vacuum Randomized Controlled Trial, 10.1097/sla.0000000000001095
  149. Menichetti F., Sganga G., Definition and Classification of Intra-abdominal Infections, 10.1179/joc.2009.21.supplement-1.3
  150. Sartelli Massimo, A focus on intra-abdominal infections, 10.1186/1749-7922-5-9
  151. Gupta Sanjay, Kaushik Robin, 10.1186/1749-7922-1-13
  152. Mishra Biplab, Subramanian Arulselvi, Sagar Sushma, Kumar Subodh, Singhal Maneesh, Kannan Umashankkar, Operative management of splenic injury in a patient with proteus syndrome, 10.4103/0974-2700.136872
  153. Reemst PH, Van Goor H, Goris RJ. SIRS, MODS and tertiary peritonitis. Eur J Surg Suppl. 1996;576:47–8. discussion 49.
  154. Chromik Ansgar M., Meiser Andreas, Hölling Janine, Sülberg Dominique, Daigeler Adrien, Meurer Kirsten, Vogelsang Heike, Seelig Matthias H., Uhl Waldemar, Identification of Patients at Risk for Development of Tertiary Peritonitis on a Surgical Intensive Care Unit, 10.1007/s11605-009-0882-y
  155. Herzog T, Chromik AM, Uhl W, Treatment of complicated intra-abdominal infections in the era of multi-drug resistant Bacteria, 10.1186/2047-783x-15-12-525
  156. Roehrborn A., Thomas L., Potreck O., Ebener C., Ohmann C., Goretzki P. E., Röher H. D., The Microbiology of Postoperative Peritonitis, 10.1086/323333
  157. Mulier Stefaan, Penninckx Freddy, Verwaest Charles, Filez Ludo, Aerts Raymond, Fieuws Steffen, Lauwers Peter, Factors Affecting Mortality in Generalized Postoperative Peritonitis: Multivariate Analysis in 96 Patients, 10.1007/s00268-002-6705-x
  158. Ordoñez Carlos A., Puyana Juan Carlos, Management of Peritonitis in the Critically Ill Patient, 10.1016/j.suc.2006.09.006
  159. Seguin P., Fedun Y., Laviolle B., Nesseler N., Donnio P.-Y., Malledant Y., Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care, 10.1093/jac/dkp439
  160. Augustin Pascal, Kermarrec Nathalie, Muller-Serieys Claudette, Lasocki Sigismond, Chosidow Denis, Marmuse Jean-Pierre, Valin Nadia, Desmonts Jean-Marie, Montravers Philippe, Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis, 10.1186/cc8877
  161. Montravers Philippe, Chalfine Annie, Gauzit Remy, Lepape Alain, Pierre Marmuse Jean, Vouillot Corinne, Martin Claude, Clinical and Therapeutic Features of Nonpostoperative Nosocomial Intra-abdominal Infections : , 10.1097/01.sla.0000114214.68169.e9
  162. Friedman N. Deborah, Health Care–Associated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections, 10.7326/0003-4819-137-10-200211190-00007
  163. Cardoso Teresa, Almeida Mónica, Friedman N Deborah, Aragão Irene, Costa-Pereira Altamiro, Sarmento António E, Azevedo Luís, Classification of healthcare-associated infection: a systematic review 10 years after the first proposal, 10.1186/1741-7015-12-40
  164. Bone Roger C., Balk Robert A., Cerra Frank B., Dellinger R. Phillip, Fein Alan M., Knaus William A., Schein Roland M.H., Sibbald William J., Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, 10.1378/chest.101.6.1644
  165. Levy Mitchell M., Fink Mitchell P., Marshall John C., Abraham Edward, Angus Derek, Cook Deborah, Cohen Jonathan, Opal Steven M., Vincent Jean-Louis, Ramsay Graham, 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference : , 10.1097/01.ccm.0000050454.01978.3b
  166. Esteban Andrés, Frutos-Vivar Fernando, Ferguson Niall D., Peñuelas Oscar, Lorente José Ángel, Gordo Federico, Honrubia Teresa, Algora Alejandro, Bustos Alejandra, García Gema, Diaz-Regañón Inmaculada Rodríguez, de Luna Rafael Ruiz, Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward* : , 10.1097/
  167. Sartelli Massimo, Catena Fausto, Di Saverio Salomone, Ansaloni Luca, Malangoni Mark, Moore Ernest E, Moore Frederick A, Ivatury Rao, Coimbra Raul, Leppaniemi Ari, Biffl Walter, Kluger Yoram, Fraga Gustavo P, Ordonez Carlos A, Marwah Sanjay, Gerych Igor, Lee Jae, Tranà Cristian, Coccolini Federico, Corradetti Francesco, Kirkby-Bott James, Current concept of abdominal sepsis: WSES position paper, 10.1186/1749-7922-9-22
  168. Singer Mervyn, Deutschman Clifford S., Seymour Christopher Warren, Shankar-Hari Manu, Annane Djillali, Bauer Michael, Bellomo Rinaldo, Bernard Gordon R., Chiche Jean-Daniel, Coopersmith Craig M., Hotchkiss Richard S., Levy Mitchell M., Marshall John C., Martin Greg S., Opal Steven M., Rubenfeld Gordon D., van der Poll Tom, Vincent Jean-Louis, Angus Derek C., The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), 10.1001/jama.2016.0287
  169. Cain Sarah E., Kohn Joseph, Bookstaver P. Brandon, Albrecht Helmut, Al-Hasan Majdi N., Stratification of the Impact of Inappropriate Empirical Antimicrobial Therapy for Gram-Negative Bloodstream Infections by Predicted Prognosis, 10.1128/aac.03935-14
  170. Guirao X, Arias J, Badía JM, García-Rodríguez JA, Mensa J, Alvarez-Lerma F, et al. Recommendations in the empiric anti-infective agents of intra-abdominal infection. Rev Esp Quimioter. 2009;22:151–72.
  171. Solomkin Joseph S., Mazuski John E., Bradley John S., Rodvold Keith A., Goldstein Ellie J.C., Baron Ellen J., O'Neill Patrick J., Chow Anthony W., Dellinger E. Patchen, Eachempati Soumitra R., Gorbach Sherwood, Hilfiker Mary, May Addison K., Nathens Avery B., Sawyer Robert G., Bartlett John G., Diagnosis and Management of Complicated Intra-Abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America, 10.1089/sur.2009.9930
  172. Solomkin Joseph S., Mazuski John E., Baron Ellen J., Sawyer Robert G., Nathens Avery B., DiPiro Joseph T., Buchman Timothy, Dellinger E. Patchen, Jernigan John, Gorbach Sherwood, Chow Anthony W., Bartlett John, Guidelines for the Selection of Anti-infective Agents for Complicated Intra-abdominal Infections, 10.1086/378702
  173. Mazuski John E., Sawyer Robert G., Nathens Avery B., DiPiro Joseph T., Schein Moshe, Kudsk Kenneth A., Yowler Charles, The Surgical Infection Society Guidelines on Antimicrobial Therapy for Intra-Abdominal Infections: An Executive Summary, 10.1089/109629602761624171
  174. Sartelli Massimo, Viale Pierluigi, Catena Fausto, Ansaloni Luca, Moore Ernest, Malangoni Mark, Moore Frederick A, Velmahos George, Coimbra Raul, Ivatury Rao, Peitzman Andrew, Koike Kaoru, Leppaniemi Ari, Biffl Walter, Burlew Clay Cothren, Balogh Zsolt J, Boffard Ken, Bendinelli Cino, Gupta Sanjay, Kluger Yoram, Agresta Ferdinando, Di Saverio Salomone, Wani Imtiaz, Escalona Alex, Ordonez Carlos, Fraga Gustavo P, Junior Gerson Alves Pereira, Bala Miklosh, Cui Yunfeng, Marwah Sanjay, Sakakushev Boris, Kong Victor, Naidoo Noel, Ahmed Adamu, Abbas Ashraf, Guercioni Gianluca, Vettoretto Nereo, Díaz-Nieto Rafael, Gerych Ihor, Tranà Cristian, Faro Mario Paulo, Yuan Kuo-Ching, Kok Kenneth Yuh Yen, Mefire Alain Chichom, Lee Jae Gil, Hong Suk-Kyung, Ghnnam Wagih, Siribumrungwong Boonying, Sato Norio, Murata Kiyoshi, Irahara Takayuki, Coccolini Federico, Lohse Helmut A Segovia, Verni Alfredo, Shoko Tomohisa, 2013 WSES guidelines for management of intra-abdominal infections, 10.1186/1749-7922-8-3
  175. Sartelli Massimo, Viale Pierluigi, Koike Kaoru, Pea Federico, Tumietto Fabio, Van Goor Harry, Guercioni Gianluca, Nespoli Angelo, Trana Cristian, Catena Fausto, Ansaloni Luca, Leppaniemi Ari, Biffl Walter, Moore Frederick A, Poggetti Renato, Pinna Antonio Daniele, Moore Ernest E, WSES consensus conference: Guidelines for first-line management of intra-abdominal infections, 10.1186/1749-7922-6-2
  176. Chow AW, Evans GA, Nathens AB, Ball CG, Hansen G, Harding GK, et al. Canadian practice guidelines for surgical intra-abdominal infections. Can J Infect Dis Med Microbiol. 2010;21:11–37.
  177. Gomi Harumi, Solomkin Joseph S., Takada Tadahiro, Strasberg Steven M., Pitt Henry A., Yoshida Masahiro, Kusachi Shinya, Mayumi Toshihiko, Miura Fumihiko, Kiriyama Seiki, Yokoe Masamichi, Kimura Yasutoshi, Higuchi Ryota, Windsor John A., Dervenis Christos, Liau Kui-Hin, Kim Myung-Hwan, TG13 antimicrobial therapy for acute cholangitis and cholecystitis, 10.1007/s00534-012-0572-0
  178. Montravers Philippe, Dupont Hervé, Leone Marc, Constantin Jean-Michel, Mertes Paul-Michel, Laterre Pierre-Francois, Misset Benoit, Bru Jean-Pierre, Gauzit Rémy, Sotto Albert, Brigand Cecile, Hamy Antoine, Tuech Jean-Jacques, Guidelines for management of intra-abdominal infections, 10.1016/j.accpm.2015.03.005
  179. Kumar Anand, Ellis Paul, Arabi Yaseen, Roberts Dan, Light Bruce, Parrillo Joseph E., Dodek Peter, Wood Gordon, Kumar Aseem, Simon David, Peters Cheryl, Ahsan Muhammad, Chateau Dan, Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock, 10.1378/chest.09-0087
  180. Tumbarello M., Trecarichi E. M., Bassetti M., De Rosa F. G., Spanu T., Di Meco E., Losito A. R., Parisini A., Pagani N., Cauda R., Identifying Patients Harboring Extended-Spectrum- -Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System, 10.1128/aac.00009-11
  181. Al-Hasan M. N., Eckel-Passow J. E., Baddour L. M., Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study : Healthcare-associated Gram-negative BSI, 10.1007/s10096-011-1424-6
  182. Ruppé Etienne, Armand-Lefèvre Laurence, Estellat Candice, Consigny Paul-Henri, El Mniai Assiya, Boussadia Yacine, Goujon Catherine, Ralaimazava Pascal, Campa Pauline, Girard Pierre-Marie, Wyplosz Benjamin, Vittecoq Daniel, Bouchaud Olivier, Le Loup Guillaume, Pialoux Gilles, Perrier Marion, Wieder Ingrid, Moussa Nabila, Esposito-Farèse Marina, Hoffmann Isabelle, Coignard Bruno, Lucet Jean-Christophe, Andremont Antoine, Matheron Sophie, High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics, 10.1093/cid/civ333
  183. McDonald L. Clifford, Trends in Antimicrobial Resistance in Health Care–Associated Pathogens and Effect on Treatment, 10.1086/499404
  184. Montravers Philippe, Augustin Pascal, Grall Nathalie, Desmard Mathieu, Allou Nicolas, Marmuse Jean-Pierre, Guglielminotti Jean, Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections, 10.1186/s13054-016-1267-8
  185. Angus Derek C., Linde-Zwirble Walter T., Lidicker Jeffrey, Clermont Gilles, Carcillo Joseph, Pinsky Michael R., Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care : , 10.1097/00003246-200107000-00002
  186. Vincent Jean-Louis, International Study of the Prevalence and Outcomes of Infection in Intensive Care Units, 10.1001/jama.2009.1754
  187. De Waele Jan, , Lipman Jeffrey, Sakr Yasser, Marshall John C, Vanhems Philippe, Barrera Groba Casiano, Leone Marc, Vincent Jean-Louis, Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome, 10.1186/1471-2334-14-420
  188. Kumar Anand, Roberts Daniel, Wood Kenneth E., Light Bruce, Parrillo Joseph E., Sharma Satendra, Suppes Robert, Feinstein Daniel, Zanotti Sergio, Taiberg Leo, Gurka David, Kumar Aseem, Cheang Mary, Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* : , 10.1097/01.ccm.0000217961.75225.e9
  189. Dellinger R. P., , Levy Mitchell M., Rhodes Andrew, Annane Djillali, Gerlach Herwig, Opal Steven M., Sevransky Jonathan E., Sprung Charles L., Douglas Ivor S., Jaeschke Roman, Osborn Tiffany M., Nunnally Mark E., Townsend Sean R., Reinhart Konrad, Kleinpell Ruth M., Angus Derek C., Deutschman Clifford S., Machado Flavia R., Rubenfeld Gordon D., Webb Steven, Beale Richard J., Vincent Jean-Louis, Moreno Rui, Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012, 10.1007/s00134-012-2769-8
  190. Paul M., Shani V., Muchtar E., Kariv G., Robenshtok E., Leibovici L., Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis, 10.1128/aac.00627-10
  191. Ferrer Ricard, Artigas Antonio, Suarez David, Palencia Eduardo, Levy Mitchell M., Arenzana Angel, Pérez Xose Luis, Sirvent Josep-Maria, Effectiveness of Treatments for Severe Sepsis : A Prospective, Multicenter, Observational Study, 10.1164/rccm.200812-1912oc
  192. Castellanos-Ortega Álvaro, Suberviola Borja, García-Astudillo Luis A., Holanda María S., Ortiz Fernando, Llorca Javier, Delgado-Rodríguez Miguel, Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study* : , 10.1097/ccm.0b013e3181d455b6
  193. Puskarich Michael A., Trzeciak Stephen, Shapiro Nathan I., Arnold Ryan C., Horton James M., Studnek Jonathan R., Kline Jeffrey A., Jones Alan E., Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol* : , 10.1097/ccm.0b013e31821e87ab
  194. Rello Jordi, Vidaur Loreto, Sandiumenge Alberto, Rodríguez Alejandro, Gualis Belen, Boque Carmen, Diaz Emili, De-escalation therapy in ventilator-associated pneumonia* : , 10.1097/01.ccm.0000145997.10438.28
  195. Álvarez-Lerma Francisco, Alvarez Bernabe, Luque Pilar, Ruiz Francisco, Dominguez-Roldan Jose-Maria, Quintana Elisabet, Sanz-Rodriguez Cesar, 10.1186/cc4919
  196. Eachempati Soumitra R., Hydo Lynn J., Shou Jian, Barie Philip S., Does De-Escalation of Antibiotic Therapy for Ventilator-Associated Pneumonia Affect the Likelihood of Recurrent Pneumonia or Mortality in Critically Ill Surgical Patients? : , 10.1097/ta.0b013e31819dca4e
  197. Garnacho-Montero J., Gutiérrez-Pizarraya A., Escoresca-Ortega A., Corcia-Palomo Y., Fernández-Delgado Esperanza, Herrera-Melero I., Ortiz-Leyba C., Márquez-Vácaro J. A., De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock, 10.1007/s00134-013-3077-7
  198. Leone Marc, , Bechis Carole, Baumstarck Karine, Lefrant Jean-Yves, Albanèse Jacques, Jaber Samir, Lepape Alain, Constantin Jean-Michel, Papazian Laurent, Bruder Nicolas, Allaouchiche Bernard, Bézulier Karine, Antonini François, Textoris Julien, Martin Claude, De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial, 10.1007/s00134-014-3411-8
  199. Silva BN, Andriolo RB, Atallah AN, Salomão R. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev. 2013;3, CD007934.
  200. Madaras-Kelly Karl, Jones Makoto, Remington Richard, Caplinger Christina, Huttner Benedikt, Samore Matthew, Description and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records data, 10.1186/s12879-015-0933-9
  201. Cisneros J.M., Neth O., Gil-Navarro M.V., Lepe J.A., Jiménez-Parrilla F., Cordero E., Rodríguez-Hernández M.J., Amaya-Villar R., Cano J., Gutiérrez-Pizarraya A., García-Cabrera E., Molina J., Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre, 10.1111/1469-0691.12191
  202. Lew KY, Ng TM, Tan M, Tan SH, Lew EL, Ling LM, et al. Safety and clinical outcomes of carbapenem de-escalation as part of anantimicrobial stewardship programme in an ESBL-endemic setting. J Antimicrob Chemother. 2015;70:1219–25.
  203. Tucker CE, Lockwood AM, Nguyen NH. Antibiotic dosing in obesity: the search for optimum dosing strategies. Clin Obes. 2014;4:287–95.
  204. Hackel Meredith A., Badal Robert E., Bouchillon Samuel K., Biedenbach Douglas J., Hoban Daryl J., Resistance Rates of Intra-Abdominal Isolates from Intensive Care Units and Non-Intensive Care Units in the United States: The Study for Monitoring Antimicrobial Resistance Trends 2010–2012, 10.1089/sur.2014.060
  205. Powell Ledford L., Wilson Samuel Eric, The Role of β-Lactam Antimicrobials as Single Agents in Treatment of Intra-Abdominal Infection, 10.1089/109629600321308
  206. Al-Hasan M. N., Lahr B. D., Eckel-Passow J. E., Baddour L. M., Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007, 10.1093/jac/dkp162
  207. Johnson James R., Owens Krista, Gajewski Abbey, Clabots Connie, Escherichia coliColonization Patterns among Human Household Members and Pets, with Attention to Acute Urinary Tract Infection, 10.1086/524844
  208. Gin Alfred, Dilay Leanne, Karlowsky James A, Walkty Andrew, Rubinstein Ethan, Zhanel George G, Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination, 10.1586/14787210.5.3.365
  209. Vardakas K. Z., Tansarli G. S., Rafailidis P. I., Falagas M. E., Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum  -lactamases: a systematic review and meta-analysis, 10.1093/jac/dks301
  210. Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, et al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum beta-lactamase bacteremia. Clin Infect Dis. 2015;60:1319–25.
  211. Harris Patrick N A, Tambyah Paul A, Paterson David L, β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?, 10.1016/s1473-3099(14)70950-8
  212. Garbino J., Villiger P., Caviezel A., Matulionyte R., Uckay I., Morel P., Lew D., A Randomized Prospective Study of Cefepime Plus Metronidazole with Imipenem-Cilastatin in the Treatment of Intra-abdominal Infections, 10.1007/s15010-007-6237-2
  213. Henry X., Amoroso A., Coyette J., Joris B., Interaction of Ceftobiprole with the Low-Affinity PBP 5 of Enterococcus faecium, 10.1128/aac.00983-09
  214. Liapikou A, Cillóniz C, Torres A. Ceftobiprole for the treatment of pneumonia: a European perspective. Drug Design, Development and Therapy. 2015;9:4565–72.
  215. Queenan A. M., Shang W., Kania M., Page M. G. P., Bush K., Interactions of Ceftobiprole with  -Lactamases from Molecular Classes A to D, 10.1128/aac.00218-07
  216. FALAGAS M. E., MATTHAIOU D. K., BLIZIOTIS I. A., Systematic review: fluoroquinolones for the treatment of intra-abdominal surgical infections : SYSTEMATIC REVIEW: FLUOROQUINOLONES IN INTRA-ABDOMINAL SURGICAL INFECTIONS, 10.1111/j.1365-2036.2006.03154.x
  217. Borcherding SM, Stevens R, Nicholas RA, Corley CR, Self T. Quinolones: A practical review of clinical uses, dosing considerations, and drug interactions. J Fam Pract. 1996;42:69–78.
  218. Ortega M., Marco F., Soriano A., Almela M., Martínez J. A., Muñoz A., Mensa J., Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome, 10.1093/jac/dkn514
  219. Banerjee Ritu, Johnston Brian, Lohse Christine, Porter Stephen B., Clabots Connie, Johnson James R., Escherichia coli Sequence Type 131 Is a Dominant, Antimicrobial-Resistant Clonal Group Associated with Healthcare and Elderly Hosts, 10.1086/669865
  220. Patterson Jan E., Antibiotic Utilization, 10.1378/chest.119.2_suppl.426s
  221. Sartelli Massimo, Antimicrobial management of intra-abdominal infections: Literature's guidelines, 10.3748/wjg.v18.i9.865
  222. FALAGAS M. E., PEPPAS G., MAKRIS G. C., KARAGEORGOPOULOS D. E., MATTHAIOU D. K., Meta-analysis: ertapenem for complicated intra-abdominal infections : META-ANALYSIS: ERTAPENEM FOR COMPLICATED INTRA-ABDOMINAL INFECTIONS, 10.1111/j.1365-2036.2008.03642.x
  223. Lepper P. M., Grusa E., Reichl H., Hogel J., Trautmann M., Consumption of Imipenem Correlates with  -Lactam Resistance in Pseudomonas aeruginosa, 10.1128/aac.46.9.2920-2925.2002
  224. Daikos G. L., Tsaousi S., Tzouvelekis L. S., Anyfantis I., Psichogiou M., Argyropoulou A., Stefanou I., Sypsa V., Miriagou V., Nepka M., Georgiadou S., Markogiannakis A., Goukos D., Skoutelis A., Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems, 10.1128/aac.02166-13
  225. Trivedi M, Patel V, Soman R, Rodriguez C, Singhal T. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials. J Assoc Physicians India. 2012;60:28–30.
  226. Dupont H., Carbon C., Monotherapy with a Broad-Spectrum Beta-Lactam Is as Effective as Its Combination with an Aminoglycoside in Treatment of Severe Generalized Peritonitis: a Multicenter Randomized Controlled Trial, 10.1128/aac.44.8.2028-2033.2000
  227. Heizmann W. R., Löschmann P.-A., Eckmann C., von Eiff C., Bodmann K.-F., Petrik C., Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria, 10.1007/s15010-014-0691-4
  228. McGovern Paul C., Wible Michele, El-Tahtawy Ahmed, Biswas Pinaki, Meyer R. Daniel, All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials, 10.1016/j.ijantimicag.2013.01.020
  229. Bassetti Matteo, McGovern Paul C., Wenisch Christoph, Meyer R. Daniel, Yan Jean Li, Wible Michele, Rottinghaus Scott T., Quintana Alvaro, Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials, 10.1016/j.ijantimicag.2015.05.012
  230. Montravers Philippe, , Dupont Hervé, Bedos Jean-Pierre, Bret Philippe, Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting, 10.1007/s00134-014-3323-7
  231. Eckmann C, Montravers P, Bassetti M, Bodmann KF, Heizmann WR, Sánchez García M, et al. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies. J Antimicrob Chemother. 2013;68 Suppl 2:ii25–35.
  232. Chen Yen-Hsu, Hsueh Po-Ren, Changing bacteriology of abdominal and surgical sepsis : , 10.1097/qco.0b013e32835635cb
  233. Tzouvelekis L. S., Markogiannakis A., Psichogiou M., Tassios P. T., Daikos G. L., Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions, 10.1128/cmr.05035-11
  234. De Pascale Gennaro, Montini Luca, Pennisi Mariano, Bernini Valentina, Maviglia Riccardo, Bello Giuseppe, Spanu Teresa, Tumbarello Mario, Antonelli Massimo, High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria, 10.1186/cc13858
  235. Falagas Matthew E, Rafailidis Petros I, Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, 10.1517/13543784.17.7.973
  236. Falagas M. E., Kasiakou S. K., Kofteridis D. P., Roditakis G., Samonis G., Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria, 10.1007/s10096-006-0191-2
  237. N��ez M. L., Simarro E., Mart�nez-Campos L., Ruiz J., G�mez J., P�rez J., Evolution of Resistance among Clinical Isolates of Acinetobacter over a 6-Year Period, 10.1007/s100960050280
  238. Garnacho‐Montero J., Ortiz‐Leyba C., Jimenez‐Jimenez F. J., Barrero‐Almodovar A. E., Garcia‐Garmendia J. L., Bernabeu‐WittelI M., Gallego‐Lara S. L., Madrazo‐Osuna J., Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP, 10.1086/374337
  239. Plachouras D., Karvanen M., Friberg L. E., Papadomichelakis E., Antoniadou A., Tsangaris I., Karaiskos I., Poulakou G., Kontopidou F., Armaganidis A., Cars O., Giamarellou H., Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria, 10.1128/aac.01361-08
  240. Nation Roger L., Garonzik Samira M., Li Jian, Thamlikitkul Visanu, Giamarellos-Bourboulis Evangelos J., Paterson David L., Turnidge John D., Forrest Alan, Silveira Fernanda P., Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?, 10.1093/cid/civ964
  241. Pontikis Konstantinos, Karaiskos Ilias, Bastani Styliani, Dimopoulos George, Kalogirou Michalis, Katsiari Maria, Oikonomou Angelos, Poulakou Garyphallia, Roilides Emmanuel, Giamarellou Helen, Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria, 10.1016/j.ijantimicag.2013.09.010
  242. Michalopoulos Argyris S., Livaditis Ioannis G., Gougoutas Vassilios, The revival of fosfomycin, 10.1016/j.ijid.2011.07.007
  243. Reffert Julia L., Smith Winter J., Fosfomycin for the Treatment of Resistant Gram-Negative Bacterial Infections : Insights from the Society of Infectious Diseases Pharmacists, 10.1002/phar.1434
  244. Eckmann Christian, Solomkin Joseph, Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections, 10.1517/14656566.2015.994504
  245. Solomkin Joseph, Hershberger Ellie, Miller Benjamin, Popejoy Myra, Friedland Ian, Steenbergen Judith, Yoon Minjung, Collins Sylva, Yuan Guojun, Barie Philip S., Eckmann Christian, Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI), 10.1093/cid/civ097
  246. Mawal Yogesh, Critchley Ian A, Riccobene Todd A, Talley Angela K, Ceftazidime–avibactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections, 10.1586/17512433.2015.1090874
  247. Mazuski John E., Gasink Leanne B., Armstrong Jon, Broadhurst Helen, Stone Greg G., Rank Douglas, Llorens Lily, Newell Paul, Pachl Jan, Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program, 10.1093/cid/ciw133
  248. Liscio Jordan L., Mahoney Monica V., Hirsch Elizabeth B., Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections, 10.1016/j.ijantimicag.2015.05.003
  249. Holden M. T. G., Hsu L.-Y., Kurt K., Weinert L. A., Mather A. E., Harris S. R., Strommenger B., Layer F., Witte W., de Lencastre H., Skov R., Westh H., Zemlickova H., Coombs G., Kearns A. M., Hill R. L. R., Edgeworth J., Gould I., Gant V., Cooke J., Edwards G. F., McAdam P. R., Templeton K. E., McCann A., Zhou Z., Castillo-Ramirez S., Feil E. J., Hudson L. O., Enright M. C., Balloux F., Aanensen D. M., Spratt B. G., Fitzgerald J. R., Parkhill J., Achtman M., Bentley S. D., Nubel U., A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic, 10.1101/gr.147710.112
  250. Skalweit Marion, Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections, 10.2147/dddt.s61436
  251. Montravers Philippe, Dupont Hervé, Gauzit Remy, Veber Benoit, Auboyer Christian, Blin Patrick, Hennequin Christophe, Martin Claude, Candida as a risk factor for mortality in peritonitis* : , 10.1097/01.ccm.0000201889.39443.d2
  252. Zappella N., Desmard M., Chochillon C., Ribeiro-Parenti L., Houze S., Marmuse J.-P., Montravers P., Positive peritoneal fluid fungal cultures in postoperative peritonitis after bariatric surgery, 10.1016/j.cmi.2015.05.024
  253. Montravers P., Mira J.-P., Gangneux J.-P., Leroy O., Lortholary O., A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units, 10.1111/j.1469-0691.2010.03360.x
  254. Pappas Peter G., Kauffman Carol A., Andes David, Benjamin, Jr. Daniel K., Calandra Thierry F., Edwards, Jr. John E., Filler Scott G., Fisher John F., Kullberg Bart‐Jan, Ostrosky‐Zeichner Luis, Reboli Annette C., Rex John H., Walsh Thomas J., Sobel Jack D., Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, 10.1086/596757
  255. Playford E. Geoffrey, Webster Angela C., Sorrell Tania C., Craig Jonathan C., Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials, 10.1093/jac/dki491
  256. Shorr Andrew F., Chung Kevin, Jackson William L., Waterman Paige E., Kollef Marin H., Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis* : , 10.1097/01.ccm.0000178352.14703.49
  257. Vardakas Konstantinos Z., Samonis George, Michalopoulos Argyris, Soteriades Elpidoforos S., Falagas Matthew E., Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials* : , 10.1097/01.ccm.0000208357.05675.c3
  258. Cruciani Mario, de Lalla Fausto, Mengoli Carlo, Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis, 10.1007/s00134-005-2794-y
  259. Cornely O.A., Bassetti M., Calandra T., Garbino J., Kullberg B.J., Lortholary O., Meersseman W., Akova M., Arendrup M.C., Arikan-Akdagli S., Bille J., Castagnola E., Cuenca-Estrella M., Donnelly J.P., Groll A.H., Herbrecht R., Hope W.W., Jensen H.E., Lass-Florl C., Petrikkos G., Richardson M.D., Roilides E., Verweij P.E., Viscoli C., Ullmann A.J., ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients, 10.1111/1469-0691.12039
  260. Knitsch W, Vincent JL, Utzolino S, François B, Dinya T, Dimopoulos G, et al. A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections. Clin Infect Dis. 2015;61(11):1671–8.
  261. Allou Nicolas, Allyn Jerome, Montravers Philippe, When and How to Cover for Fungal Infections in Patients with Severe Sepsis and Septic Shock, 10.1007/s11908-011-0204-x
  262. Shields R. K., Nguyen M. H., Press E. G., Clancy C. J., Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance, 10.1128/aac.04134-14
  263. Muller M., dela Pena A., Derendorf H., Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue, 10.1128/aac.48.5.1441-1453.2004
  264. Gonzalez D., Schmidt S., Derendorf H., Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents, 10.1128/cmr.00092-12
  265. Seguin P., Verdier M. C., Chanavaz C., Engrand C., Laviolle B., Donnio P.-Y., Malledant Y., Plasma and peritoneal concentration following continuous infusion of cefotaxime in patients with secondary peritonitis, 10.1093/jac/dkn522
  266. Buijk S. L. C. E., Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections, 10.1093/jac/49.1.121
  267. Dahyot-Fizelier Claire, Lefeuvre Sandrine, Laksiri Leila, Marchand Sandrine, Sawchuk Ronald J., Couet William, Mimoz Olivier, Kinetics of Imipenem Distribution into the Peritoneal Fluid of Patients with Severe Peritonitis Studied by Microdialysis : , 10.2165/11319370-000000000-00000
  268. Karjagin J, Lefeuvre S, Oselin K, Kipper K, Marchand S, Tikkerberi A, Starkopf J, Couet W, Sawchuk RJ, Pharmacokinetics of Meropenem Determined by Microdialysis in the Peritoneal Fluid of Patients With Severe Peritonitis Associated With Septic Shock, 10.1038/sj.clpt.6100312
  269. Levison Matthew E, Pharmacodynamics of antimicrobial drugs, 10.1016/j.idc.2004.04.012
  270. Roberts Jason A, Abdul-Aziz Mohd H, Lipman Jeffrey, Mouton Johan W, Vinks Alexander A, Felton Timothy W, Hope William W, Farkas Andras, Neely Michael N, Schentag Jerome J, Drusano George, Frey Otto R, Theuretzbacher Ursula, Kuti Joseph L, Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions, 10.1016/s1473-3099(14)70036-2
  271. Leekha Surbhi, Terrell Christine L., Edson Randall S., General Principles of Antimicrobial Therapy, 10.4065/mcp.2010.0639
  272. Pea Federico, Viale Pierluigi, Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock – does the dose matter?, 10.1186/cc7774
  273. Lau W. K., Mercer D., Itani K. M., Nicolau D. P., Kuti J. L., Mansfield D., Dana A., Randomized, Open-Label, Comparative Study of Piperacillin-Tazobactam Administered by Continuous Infusion versus Intermittent Infusion for Treatment of Hospitalized Patients with Complicated Intra-Abdominal Infection, 10.1128/aac.00329-06
  274. Dulhunty Joel M., Roberts Jason A., Davis Joshua S., Webb Steven A. R., Bellomo Rinaldo, Gomersall Charles, Shirwadkar Charudatt, Eastwood Glenn M., Myburgh John, Paterson David L., Starr Therese, Paul Sanjoy K., Lipman Jeffrey, A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis, 10.1164/rccm.201505-0857oc
  275. Lodise T. P., Lomaestro B., Drusano G. L., Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy, 10.1086/510590
  276. Lorente Leonardo, Jiménez Alejandro, Martín María M., Iribarren José Luis, Jiménez Juan José, Mora María L., Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion, 10.1016/j.ijantimicag.2008.10.025
  277. Hatala Rosemarie, Once-Daily Aminoglycoside Dosing in Immunocompetent Adults : A Meta-Analysis, 10.7326/0003-4819-124-8-199604150-00003
  278. Udy Andrew A., Baptista João P., Lim Noelle L., Joynt Gavin M., Jarrett Paul, Wockner Leesa, Boots Robert J., Lipman Jeffrey, Augmented Renal Clearance in the ICU : Results of a Multicenter Observational Study of Renal Function in Critically Ill Patients With Normal Plasma Creatinine Concentrations*, 10.1097/ccm.0000000000000029
  279. Gladman Marc A, Knowles Charles H, Gladman Lucy J, Payne John G, Intra-operative culture in appendicitis: traditional practice challenged, 10.1308/003588404323043346
  280. Davies Huw O.B., Alkhamesi Nawar A., Dawson Peter M., Peritoneal fluid culture in appendicitis: Review in changing times, 10.1016/j.ijsu.2010.06.016
  281. Marchese Anna, Esposito Susanna, Barbieri Ramona, Bassetti Matteo, Debbia Eugenio, Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?, 10.1186/1471-2334-12-181
  282. Wolfensberger Aline, Sax Hugo, Weber Rainer, Zbinden Reinhard, Kuster Stefan P., Hombach Michael, Change of Antibiotic Susceptibility Testing Guidelines from CLSI to EUCAST: Influence on Cumulative Hospital Antibiograms, 10.1371/journal.pone.0079130
  283. van der Bij A.K., van Dijk K., Muilwijk J., Thijsen S.F.T., Notermans D.W., de Greeff S., van de Sande-Bruinsma N., Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia, 10.1111/j.1469-0691.2012.03996.x
  284. Polsfuss S., Bloemberg G. V., Giger J., Meyer V., Hombach M., Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum  -lactamase production in clinical Enterobacteriaceae isolates, 10.1093/jac/dkr400
  285. Hombach Michael, Mouttet Brice, Bloemberg Guido V., Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates, 10.1093/jac/dkt136
  286. Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev. 2005;3, CD001439.
  287. Mazeh Haggi, Mizrahi Ido, Dior Uri, Simanovsky Natalia, Shapiro Mervyn, Freund Herbert R., Eid Ahmed, Role of Antibiotic Therapy in Mild Acute Calculus Cholecystitis: A Prospective Randomized Controlled Trial, 10.1007/s00268-012-1572-6
  288. Regimbeau Jean Marc, Fuks David, Pautrat Karine, Mauvais Francois, Haccart Vincent, Msika Simon, Mathonnet Muriel, Scotté Michel, Paquet Jean Christophe, Vons Corinne, Sielezneff Igor, Millat Bertrand, Chiche Laurence, Dupont Hervé, Duhaut Pierre, Cossé Cyril, Diouf Momar, Pocard Marc, Effect of Postoperative Antibiotic Administration on Postoperative Infection Following Cholecystectomy for Acute Calculous Cholecystitis : A Randomized Clinical Trial, 10.1001/jama.2014.7586
  289. Bhangu Aneel, Søreide Kjetil, Di Saverio Salomone, Assarsson Jeanette Hansson, Drake Frederick Thurston, Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management, 10.1016/s0140-6736(15)00275-5
  290. Søreide Kjetil, Thorsen Kenneth, Harrison Ewen M, Bingener Juliane, Møller Morten H, Ohene-Yeboah Michael, Søreide Jon Arne, Perforated peptic ulcer, 10.1016/s0140-6736(15)00276-7
  291. Sawyer Robert G., Claridge Jeffrey A., Nathens Avery B., Rotstein Ori D., Duane Therese M., Evans Heather L., Cook Charles H., O’Neill Patrick J., Mazuski John E., Askari Reza, Wilson Mark A., Napolitano Lena M., Namias Nicholas, Miller Preston R., Dellinger E. Patchen, Watson Christopher M., Coimbra Raul, Dent Daniel L., Lowry Stephen F., Cocanour Christine S., West Michaela A., Banton Kaysie L., Cheadle William G., Lipsett Pamela A., Guidry Christopher A., Popovsky Kimberley, Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection, 10.1056/nejmoa1411162
  292. Riccio Lin M., Popovsky Kimberley A., Hranjec Tjasa, Politano Amani D., Rosenberger Laura H., Tura Kristin C., Sawyer Robert G., Association of Excessive Duration of Antibiotic Therapy for Intra-Abdominal Infection with Subsequent Extra-Abdominal Infection and Death: A Study of 2,552 Consecutive Infections, 10.1089/sur.2012.077
  293. Hochreiter Marcel, Köhler Thomas, Schweiger Anna, Keck Fritz, Bein Berthold, von Spiegel Tilman, Schroeder Stefan, Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial, 10.1186/cc7903
  294. Xiao Zhengwen, Wilson Crystal, Robertson Helen Lee, Roberts Derek J., Ball Chad G., Jenne Craig N., Kirkpatrick Andrew W., Inflammatory mediators in intra-abdominal sepsis or injury – a scoping review, 10.1186/s13054-015-1093-4
  295. Tschaikowsky Klaus, Hedwig-Geissing Monika, Braun Giovanni G., Radespiel-Troeger Martin, Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis, 10.1016/j.jcrc.2010.04.011
  296. Azevedo José Raimundo Araujo de, Torres Orlando Jorge Martins, Czeczko Nicolau Gregori, Tuon Felipe Francisco, Nassif Paulo Afonso Nunes, Souza Gleim Dias de, Procalcitonina como biomarcador de prognóstico da sepse grave e choque séptico, 10.1590/s0100-69912012000600003
  297. Schroeder S., Hochreiter M., Koehler T., Schweiger A.-M., Bein B., Keck F. S., von Spiegel T., Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study, 10.1007/s00423-008-0432-1
  298. Jung Boris, Molinari Nicolas, Nasri Mourad, Hajjej Zied, Chanques Gerald, Jean-Pierre Helene, Panaro Fabrizio, Jaber Samir, Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock, 10.1186/cc13082
  299. Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. Morb Mortal Wkly Rep. 2009;58:256–60.